Brief: Mereo Biopharma Regains Compliance With Nasdaq Minimum Bid Price Requirement
08/05/2023 18:40
May 8 (Reuters) - Mereo Biopharma Group PLC:
* MEREO BIOPHARMA REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID
PRICE
REQUIREMENT
Further company coverage: MAH0y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand